Clinical study of dextromethorphan in treatment of patients with poststroke pseudobulbar affect symp-toms
10.3969/j.issn.1006-5725.2018.06.008
- VernacularTitle:美沙芬治疗脑梗死后强哭强笑综合征30例
- Author:
Jianbin ZHONG
1
;
Xie LI
;
Simin ZHONG
;
Chibang CHEN
;
Shijun ZHANG
;
Qiaoli WU
;
Lishi PAN
Author Information
1. 广州市增城区人民医院(中山大学附属博济医院)神经内科 广州511300
- Keywords:
cerebral infarction;
dextromethorphan;
pseudobulbar affect symptoms;
center for neuro-logic studies-lability scale;
activity of daily living
- From:
The Journal of Practical Medicine
2018;34(6):906-908
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical effect of dextromethorphan and its effect on daily living of patients with poststroke pseudobulbar affect. Methods Sixty patients with poststroke pseudobulbar affect admitted in our hospital from May 2013 to October 2016 were enrolled. Then they were randomly divided into the control group and the treatment group,with 30 patients in each group.Patients in the control group were treated with fluox-etine therapy and patients in the treatment group were treated with dextromethorphan therapy.The center for neuro-logic study lability scale(CNS-LS)and activity of daily living(Barthel index,BI)before and 30 days after the treat-ments in the two groups had been accessed. Results Thirty days after the treatment,CNS-LS of the treatment group had obvious improvement compared with that before treatment(P < 0.01),but CNS-LS of the control group had no obvious improvement compared with that before treatment(P > 0.05). And significant improvement has been found 30 days after the treatment between the two groups(P<0.01).Furthermore,significant difference was found on BI between these two groups(P<0.05).Conclusions Dextromethorphan is effective in treatment of pa-tients with poststroke pseudobulbar affect and it can improve the activity of daily living of these patients.
